Bright Lisa 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Apr 3, 2019
Insider Transaction Report
Form 4
Bright Lisa
CCO & Corp Affairs Officer
Transactions
- Sale
Common Stock
2019-04-03$115.01/sh−594$68,316→ 20,982 total - Tax Payment
Common Stock
2019-04-01$111.50/sh−531$59,207→ 21,576 total
Footnotes (2)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock awards previously granted to the reporting person.
- [F2]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.